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Addiction: Reward, Motivation and 
Stress
George F. Koob, Ph.D.
Professor
Molecular and Integrative Neurosciences Department 
The Scripps Research Institute
La Jolla, California
The Neurocircuitry of Drug Addiction: Neuroadaptive 
Mechanisms from the ―Dark Side‖
• What is Addiction?
1. Conceptual framework
2. The ‘dark side’ of compulsivity
• Animal Models for the Motivational Effects of Dependence
1. Brain stimulation reward
2. Place aversion
3. Anxiogenic-like responses in the plus maze and defensive burying tests
4. Escalation in drug self-administration with prolonged access 






1. Development of CRF1 antagonists for treatment of addiction





Drug Addiction — Chronically relapsing disorder that is characterized by a 
compulsion to seek and take drug, loss of control in limiting intake, and 
emergence of a negative emotional state (e.g. dysphoria, anxiety, 
irritability) when access to the drug is prevented (here, defined as the 
“dark side” of addiction)
Extended Amygdala — Forebrain macrostructure composed of central 
medial amygdala, bed nucleus of the stria terminalis, and a transition 
zone in the medial part of the nucleus accumbens
Corticotropin-Releasing Factor — 41 amino acid polypeptide “brain 
stress” neurotransmitter that controls hormonal, sympathetic, and 
behavioral responses to stressors
Drug addiction is conceptualized as a chronic 
relapsing syndrome that moves from an impulse 
control disorder involving positive reinforcement to 
a compulsive disorder involving negative 
reinforcement
Drug Addiction
From: Koob GF, Alcohol Clin Exp Res, 2003, 27:232-243.
Stages of the Addiction Cycle
Animal Models for the Motivational Components 
of Dependence
Animal Models for the Withdrawal/Negative Affect Stage
1. Brain stimulation reward
2. Place aversion
3. Anxiogenic-like responses in elevated plus maze and
defensive burying
Animal Models for the Transition to Addiction
1. Drug taking in selected lines of drug preferring animals 
2. Withdrawal-induced drug taking
3. Escalation in drug self-administration with prolonged
access
4. Drug taking despite aversive consequences
Cocaine Self-Administration
From: Caine SB, Lintz R and Koob GF. in Sahgal A (ed) Behavioural Neuroscience: A Practical Approach, vol. 2, 
IRL Press, Oxford, 1993, pp. 117-143.
Neurochemical Circuitry in Drug Reward
Potential Substrates in the Extended Amygdala 
for the Motivational Effects of Drug Dependence
Heimer L and Alheid G, Piecing together the puzzle of basal forebrain anatomy. In: Napier TC, Kalivas 
PW and Hanin I (Eds), The Basal Forebrain: Anatomy to Function (series title: Advances in Experimental
Medicine and Biology, Vol. 295), Plenum Press, New York, 1991, pp. 1-42.
Modified from:
Equilibrium State for a Homeostatic Regulatory 
System in a Nondependent and Dependent 
Organism
From: Martin WR, A homeostatic and redundancy theory of tolerance to and dependence on narcotic analgesics.
in Wikler A (Ed.), The Addictive States (series title: Its Research Publications, vol. 46), Williams and Wilkins, 
Baltimore, 1968, pp. 206-225.
Standard Pattern of Affective Dynamics Produced
by Novel and Repeated Unconditioned Stimulus
From: Solomon RL, American Psychologist, 1980, 35:691-712.
Mood Changes Associated with Plasma Levels
of Cocaine During Coca Paste Smoking
From: Van Dyke C and Byck R, Cocaine, Scientific American, 1982, 246:123-141. 
Sampling of Interstitial Neurochemicals
by in vivo Microdialysis
• Allows sampling of neurochemicals in 
conscious animals (correlate brain 
chemistry with behavior).
• Implanted so that semi-permeable 
probe tip is in specific brain region of 
interest.
• Substances below the membrane MW 
cutoff diffuse across membrane based 
on concentration gradient.
• Both neurochemical sampling and 
localized drug delivery are possible.
Collaborators: Dr. Friedbert Weiss, Dr. Larry Parsons, Dr. Emilio Merlo-Pich, Dr. Regina Richter
Extracellular DA and 5-HT in the Nucleus 
Accumbens During Cocaine Self-Administration 
and Withdrawal
From: Parsons LH, Koob GF and Weiss F, J Pharmacol Exp Ther, 1995, 274:1182-1191.
Withdrawal from chronic drugs of abuse produces 
a reward (motivational) dysregulation as measured 





Adapted from: Markou A and Koob GF, Physiol Behav, 1992, 51:111-119.
Elevations in ICSS Reward Thresholds During Withdrawal
Reward Transmitters Implicated in the 
Motivational Effects of Drugs of Abuse
Dopamine … ―dysphoria‖
Opioid peptides ... pain
Serotonin … ―dysphoria‖









Major CRF-Immunoreactive Cell Groups and
Fiber Systems in the Rat Brain
From: Swanson LW, Sawchenko PE, Rivier J and Vale W, Neuroendocrinology, 1983, 36:165-186.
CRF Produces Arousal, Stress-like Responses,
and a Dysphoric, Aversive State
Paradigm CRF Agonist CRF Antagonist
Acoustic startle Facilitates startle Blocks fear-potentiated startle
Elevated plus maze Suppresses exploration Reverses suppression of exploration
Defensive burying Enhances burying Reduces burying
Fear conditioning Induces conditioned fear Blocks acquisition of conditioned 
fear
Cued electric shock Enhances freezing Attenuates freezing
Taste / Place Conditioning Produces place aversion Weakens drug-induced place 
aversion

Chronic cocaine administration produces a 
dependence syndrome that is reversed by 
blockade of CRF function.
Cocaine
Defensive Burying: Active Anxiety-Like Behavior
Habituation
• Two 45-min sessions in test cage
• No shock probe present
Testing
• Electrified shock probe present
• Probe delivers a single, < 1 sec, 1.5 mA 
shock on contact
• Probe is shut off after shock
• Defensive burying scored for 10 min
Endpoints
• Latency to bury
• Duration of burying
• Duration of other active behaviors
Effect of CRF Antagonist D-Phe-CRF12-41
Administered ICV on Anxiogenic-Like Effect 
Following Chronic Cocaine Administration
From: Basso AM, Spina M, Rivier J, Vale W and Koob GF, Psychopharmacology, 1999, 145:21-30.
Extracellular CRF Levels in the Central Nucleus of 
the Amgydala During Cocaine Self-Administration 
and Subsequent Withdrawal
From: Richter RM and Weiss F, Synapse, 1999, 32:254-261.





1) Initial Training Phase
Short Access (n=12)
22 x 1-hr SA session
2) Escalation Phase
Long Access (n=12)





Protocol from: Ahmed SH and Koob, Science, 1998, 282:298-300.
Change in Brain Stimulation Reward Thresholds 
in Long-Access (Escalation) vs. Short-Access 
(Non-Escalation) Rats
From: Ahmed SH, Kenny PJ, Koob GF and Markou A, Nature Neurosci, 2002, 5:625-627.
Dose-Dependent Decrease of Cocaine Intake
with Administration of a CRF1 Antagonist
From: Specio SE, Zorrilla EP, O’Dell LE and Koob GF, unpublished results.
Pieter Bruegel
Chronic alcohol exposure produces a 
dependence syndrome that is reversed by 
blockade of CRF function.
Alcohol
Elevated Plus Maze
• Unconditioned approach/avoidance behavior
• 3 underlying factors: anxiety, activity, assessment of risk
• Predictive validity for anxiolytic and anxiogenic drugs
Competitive CRF Antagonist -Helical CRF9-41
Injected into Central Nucleus of the Amygdala
Blocks the Anxiogenic Effects of Alcohol Withdrawal
From: Rassnick S, Heinrichs SC, Britton K and Koob GF, Brain Res, 1993, 605:25-32. 
Extracellular CRF Levels in the Central
Amygdala During Ethanol Withdrawal
From: Merlo-Pich E, Lorang M, Yeganeh M, Rodriquez de Fonseca F, Koob GF and Weiss F, J Neurosci, 1995,
15:5439-5447.

Protocol for Initiation of Lever Pressing for
Oral Ethanol Self-Administration in the Rat
Initiation of the free-choice operant task: 
ethanol (10%) and water
Rats trained to lever press on a FR-1 
schedule
Ethanol added to the saccharin solution










































Training Saccharin (w/v) EtOH (w/v)
From: Rassnick S, Pulvirenti L and Koob GF, Alcohol, 1993, 10:127-132.
Ethanol Dependence Induction
From: Rassnick S, Heinrichs SC, Britton KT and Koob GF,
Brain Res, 1993, 605:25-32.
From: Rogers J, Wiener SG and Bloom FE,
Behav Neural Biol, 1979, 27:466-486.
Enhanced Ethanol Self-Administration
During Withdrawal in Dependent Animals
From: Funk C and Koob GF, unpublished results.
Effects of a Competitive CRF Antagonist Injected ICV 
on Ethanol Self-Administration During Withdrawal in 
Dependent Rats
(60 min session 2 h into withdrawal)
From: Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP and Koob GF, Alcohol Clin Exp Res, 2002,
26:1494-1501.
Effect of CRF Antagonist D-Phe-CRF12-41
– Central Nucleus of the Amygdala –
From: Funk C, O’Dell LE and Koob GF, unpublished results.
Effect of CRF Antagonist D-Phe-CRF12-41
– Lateral Bed Nucleus of the Stria Terminalis –
From: Funk C, O’Dell LE and Koob GF, unpublished results.
Effect of CRF Antagonist D-Phe-CRF12-41
– Nucleus Accumbens Shell –




From: Funk C, Zorrilla EP, Lee MJ, Rice KC and Koob GF, unpublished results.
Interaction of CRF Antagonists in Animal Models 
of Protracted Abstinence
1. CRF antagonists injected into the extended amygdala 
block stress-induced reinstatement of drug seeking
Erb S, Salmaso N, Rodaros D and Stewart J, Psychopharmacology, 2001, 158:360-365
Liu X and Weiss F, J Neurosci, 2002, 22:7856-7861
Funk D, Li Z, Shaham Y and Le AD, Neuroscience, 2003, 122:1-4
2. CRF antagonists injected i.c.v. block stress-induced 
anxiogenic-like responses and excessive drinking during 
protracted abstinence
Valdez GR, Zorrilla EP, Roberts AJ and Koob GF, Alcohol, 2003, 29:55-60.
3. CRF1 knockout mice show a blunted anxiogenic-like 
response to alcohol withdrawal and a blockade of 
excessive drinking during protracted abstinence
Chu K, Koob GF, Cole M and Roberts AJ, submitted
The extended amygdala is a rich 
substrate for neurochemical and 
neurocircuitry interactions that produce 
the ―dark side‖ of motivation.
Extended Amygdala
Neurochemical Changes in the Extended Amygdala during 
the Development of Dependence:
Implications for Emotional Processing
Neurochemical Changes Associated with the 
Transition from Drug Use to Dependence
From: Roberts AJ and Koob GF, Alcohol: ethanol antagonists/amethystic agents. in Adelman G and Smith BH (Eds.), 
Encyclopedia of Neuroscience, 3rd edn, Elsevier, New York, 2003 [http://203.200.24.140:8080/Neuroscience].
Conclusions
CRF in the extended amygdala is recruited during the development of 
dependence and has motivational significance for drug seeking.
Compulsive drug taking associated with addiction derives both from 
decreases in reward neurotransmission and from recruitment of anti-
reward systems (―dark side‖ of addiction).
Other neurochemical elements in the extended amygdala—such as 
norepinephrine, NPY and galanin—may have a role in motivational 
neuroadaptation associated with drug dependence.
The common interface in the extended amygdala of the 
neurochemistry of addiction and pain and fear conditioning pathways 
provides a heuristic framework for exploring the neural basis of 
negative emotional states.































Neurobiology of Drug Addiction
Current Collaborators
Support from:
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases
Pearson Center for Alcoholism and Addiction Research
Jean Rivier
Catherine Rivier
Tamas Bartfai
George Siggins
Marisa Roberto
Kenner Rice
Kim Janda
Laura O’Dell
Robert Purdy
Walter Francesconi
Sheila Specio
Marc Azar
Floyd Bloom
Barbara Mason
Michel Le Moal
Luis Stinus
Friedbert Weiss
Athina Markou
Amanda Roberts
Larry Parsons
Pietro Sanna
Luigi Pulvirenti
Eric Zorrilla
Wylie Vale
